打印 妙佑医疗国际的方法妙佑医疗国际名列前茅的医生可为前列腺癌患者提供专业护理。在妙佑医疗国际,您可以获得: 先进的治疗方案。 即使在激素治疗失效后,妙佑医疗国际的专科医生也能充分利用最新的治疗创新成果,包括临床试验。 团队协作。 在妙佑医疗国际,肿瘤科医生、泌尿科医生、放射肿瘤科医生、病理科医生和放射科医生组成的多学科团队,为前列腺癌患者提供综合治疗。 经验丰富的医护团队。 每年都会有数千名前列腺癌患者在妙佑医疗国际接受治疗。这些经验意味着您的医护团队能够运用相应知识和资源,准确地为您提供您所需要的医疗服务。妙佑医疗的专科医生不仅在该疾病的某一特定方面经验丰富,而且在涉及前列腺癌治疗的所有专科领域都有很深的造诣。 全美公认的专业技能。 妙佑医疗国际综合癌症中心符合美国国家癌症研究所指定的综合癌症中心的严格标准。符合这些标准即说明该中心在癌症预防、诊断和治疗方面的卓越科学成就和多专科诊疗模式均获得认可。妙佑医疗国际综合癌症中心是美国国家癌症研究所指定综合癌症中心中唯一一家设有三地院区的机构,院区分别位于亚利桑那州、佛罗里达州和明尼苏达州。 专长与排名自 1990 年开始发布以来,妙佑医疗国际一直在《美国新闻与世界报道》排名中稳居最佳癌症医院之列。最近,在《美国新闻与世界报道》全美最佳癌症医院评选中,妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际佛罗里达州杰克逊维尔院区和妙佑医疗国际亚利桑那州凤凰城/斯科茨代尔院区均被评为最佳癌症医院之一。 妙佑医疗国际亚利桑那州院区 妙佑医疗国际佛罗里达州院区 妙佑医疗国际明尼苏达州院区 妙佑区域医疗系统 伦敦妙佑医疗中心 有关账单和保险的更多信息: 妙佑医疗国际亚利桑那州、佛罗里达州以明尼苏达州院区 妙佑区域医疗系统 来自妙佑医疗国际员工 申请预约 医生与科室 July 15, 2025 打印显示参考文献 Prostate cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459. Accessed May 27, 2025. Prostate cancer: Early stage. National Comprehensive Cancer Network. https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=49. Accessed May 27, 2025. Lowrance W, et al. Updates to advanced prostate cancer: AUA/SUO guideline (2023). The Journal of Urology. 2023; doi:10.1097/JU.0000000000003452. Hormone therapy for prostate cancer. National Cancer Institute. https://www.cancer.gov/types/prostate/prostate-hormone-therapy-fact-sheet. Accessed May 27, 2025. Smith MR. Side effects of androgen deprivation therapy. https://www.uptodate.com/contents/search. Accessed Feb. 16, 2023. Dmochowski RR, et al., eds. Management of recurrent and newly metastatic prostate cancer. In: Campbell-Walsh-Wein Urology. 13th ed. Elsevier; 2026. https://www.clinicalkey.com. Accessed May 27, 2025. Hussain M, et al. Metastatic hormone-sensitive prostate cancer and combination treatment outcomes: A review. JAMA Oncology. 2024; doi:10.1001/jamaoncol.2024.0591. Hamid AA, et al. Metastatic hormone-sensitive prostate cancer: Toward an era of adaptive and personalized treatment. American Society of Clinical Oncology Educational Book. 2023; doi:10.1200/EDBK_390166. Gudenkauf LM, et al. Balancing hormone therapy: Mitigating adverse effects of androgen-deprivation therapy and exploring alternatives in prostate cancer management. American Society of Clinical Oncology Educational Book. 2024; doi:10.1200/EDBK_433126. Boue A, et al. Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis. Cancer. 2024; doi:10.1002/cncr.35210. Solanki AJ, et al. A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer. Cancer. 2024; doi:10.1002/cncr.35285. Lupron (prescribing information). AbbVie Inc.; 2023. https://www.lupron.com/pi.html. Accessed June 6, 2025. Zoladex (prescribing information). AstraZeneca Pharmaceuticals LP; 2023. https://www.zoladexhcp.com/dosing-administration/. Accessed June 6, 2025. Vaz R, et al. Testicular cancer — Surgical treatment. Frontiers in Endocrinology. 2019; doi:10.3389/fendo.2019.00308. Dawson NA, et al. Overview of the treatment of castration-resistant prostate cancer (CRPC). https://www.uptodate.com/contents/search. Accessed June 12, 2025. Hormone therapy for prostate cancer. National Cancer Institute. https://www.cancer.gov/types/prostate/prostate-hormone-therapy-fact-sheet. Accessed June 12, 2025. Harris WP, et al. Androgen deprivation therapy: Progress in understanding mechanisms of resistance and optimizing androgen depletion. Nature Clinical Practice Urology; 2009. doi:10.1038/ncpuro1296. Cancer stat facts: Prostate cancer. National Cancer Institute. https://seer.cancer.gov/statfacts/html/prost.html. Accessed June 12, 2025. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024. Questions to ask about prostate cancer. American Cancer Society. https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/talking-with-doctor.html. Accessed June 18, 2025. Questions to ask about cancer care. National Comprehensive Cancer Network. https://www.nccn.org/patientresources/patient-resources/resources-for-patients-caregivers/questions-to-ask-about-cancer. Accessed June 18, 2025. Anheuser P, et al. Complications associated with inguinal orchiectomy and scrotal orchiectomy. Urologe. 2014; doi:10.1007/s00120-014-3487-3. Hormone therapy for advanced prostate cancer. Mayo Clinic Press. https://mcpress.mayoclinic.org/cancer/hormone-therapy-for-advanced-prostate-cancer. Accessed June 18, 2025. 相关 Metastatic castration-resistant prostate cancer (mCRPC) Prostate cancer recurrence 前列腺癌 前列腺癌 转移性前列腺癌 4 期 显示更多相关内容 Mayo Clinic 新闻 Mayo Clinic Minute: Improvements in prostate surgery (Video) New hope for patients with metastatic prostate cancer 产品与服务 书籍:《妙佑医疗国际前列腺健康医护指南》 书籍:《妙佑医疗国际家庭健康手册》 简报:妙佑医疗国际卫生来信 — 数字版 显示更多来自妙佑医疗国际的产品和服务 前列腺癌激素治疗关于医生与科室在 Mayo Clinic 治疗 PRC-20167641 医学检查与医疗程序 前列腺癌激素治疗